LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

Kodu・Aktsiate loetelu・Stevanato Group SpA

Stevanato Group SpA

Avatud

SektorTervishoid

25.25 6.14

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

23.62

Max

25.25

Põhinäitajad
By Trading Economics
Sissetulek	4M 39M
Müük	23M 280M
P/E Sektori keskmine	43.298 77.256
Dividenditootlus	0.21
Kasumimarginaal	13.965
Töötajad	5,521
EBITDA	5.2M 62M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+15.2% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	0.21% 2.33%
Järgmine tulemuste avaldamine	6. nov 2025

Turustatistika
By TradingEconomics
Turukapital	-243M 6.7B
Eelmine avamishind	19.11
Eelmine sulgemishind	25.25

Uudiste sentiment

By Acuity

50%

165 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

21.56 / 22.61 Toetus ja vastupanu

Stevanato Group SpA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. nov 2025, 23:51 UTC

Tulu

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5. nov 2025, 23:10 UTC

Tulu

DBS Third Quarter Net Dips 2.0%

5. nov 2025, 22:55 UTC

Tulu

Arm Holdings 2Q Profit Climbs on Record Demand

5. nov 2025, 22:23 UTC

Tulu

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5. nov 2025, 23:52 UTC

Tulu

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5. nov 2025, 23:49 UTC

Tulu

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5. nov 2025, 23:49 UTC

Tulu

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5. nov 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5. nov 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5. nov 2025, 23:12 UTC

Tulu

Nutrien 3Q Adj EPS 97c >NTR.T

5. nov 2025, 23:11 UTC

Tulu

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5. nov 2025, 23:10 UTC

Tulu

Nutrien 3Q Sales $6.01B >NTR.T

5. nov 2025, 23:10 UTC

Market Talk

Tulu

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5. nov 2025, 23:10 UTC

Tulu

Nutrien 3Q EPS 96c >NTR.T

5. nov 2025, 23:04 UTC

Tulu

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5. nov 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5. nov 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5. nov 2025, 22:55 UTC

Tulu

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5. nov 2025, 22:51 UTC

Tulu

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5. nov 2025, 22:50 UTC

Tulu

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5. nov 2025, 22:44 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5. nov 2025, 22:43 UTC

Market Talk

Tulu

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5. nov 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. nov 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5. nov 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5. nov 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Responds to Delaware Chancery Court Ruling

5. nov 2025, 22:01 UTC

Tulu

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5. nov 2025, 22:01 UTC

Tulu

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Võrdlus sarnastega

Hinnamuutus

Stevanato Group SpA Prognoos

Hinnasiht

By TipRanks

15.2% tõus

12 kuu keskmine prognoos

Keskmine 28.5 USD 15.2%

Kõrge 32 USD

Madal 24 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Stevanato Group SpA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Stevanato Group SpA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

21.56 / 22.61Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

165 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.